• Blog Post

Small pharmacy makes big COVID-19 vaccine impact

Jul 30th, 2021

Vaccine Impact News: From Troy, New York

The Genoa Healthcare pharmacy located within the Unity House of Troy may be on the small side, but it has made a big impact in its Troy, New York, community by administering COVID-19 vaccines.


The pharmacy was one of the first Genoa Healthcare sites in New York State to receive the vaccine. The pharmacy team wasted no time letting consumers and staff members know that the vaccine was available to them, and communicating about vaccine ability with the broader community. A few weeks ago, the pharmacy — which serves about 160 people per month — hit a major milestone of 1,000 vaccine shots administered.


“The first few weeks we were fielding hundreds of calls and inquiries a day,” said Kristen Bohne, site manager for the Troy, New York, Genoa pharmacy. “Once vaccine demand slowed, we continued working hard to ensure people knew there were available vaccines at our site. Our clinic also provides a daily free meal to members of the community, so every day we would connect with those people to sign them up for the vaccine.”


The Troy pharmacy is located in an underserved area, and Bohne said that being able to administer vaccines to people who don’t have permanent housing, have high anxiety levels or do not feel comfortable entering a hospital or a large clinic has helped build a sense of community.


People with serious mental illness are at an increased risk of contracting COVID-19 and are also more likely to be hospitalized and experience serious complications, including death. This group faces additional barriers to vaccination and limited access to preventive care.


Consumers feel comfortable at Unity House and the Genoa pharmacy, which has helped ensure people return for their second doses, Bohne added. “People were extremely appreciative of the opportunity to be vaccinated,” she said.

Site manager Kristen Bohne and her team in Troy, New York, recently reached a milestone of administering 1,000 COVID-19 vaccinations.

Recent Posts


  • Blog Post
  • Webinar
For consumers living with Tardive Dyskinesia, Genoa Healthcare’s Clinical Assistance Program offers personalized support

Tardive Dyskinesia – a neurological disorder linked to prolonged use of antipsychotic medications – impacts over 600,000 individuals each year. Did you know that 50% of consumers taking TD medication...

  • Blog Post
A foundation to build on: 3 ways an engaged pharmacy partner helps you deliver whole-person health

A recent survey found that nearly 60% of behavioral health, primary care and complex care providers reported that their organization currently offered or had plans to begin offering integrated care...

  • Clinical Insights
  • Webinar
Understanding Tardive Dyskinesia: What you need to know

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...

  • Blog Post
340B 101: What your clinic needs to know

For qualified clinics and organizations, the 340B Drug Pricing Program offers savings on prescription drug costs, helping boost offerings and outcomes for people who need it most. Wondering if your...